(Q40312310)

English

A recombinant baculovirus-expressed S glycoprotein vaccine elicits high titers of SARS-associated coronavirus (SARS-CoV) neutralizing antibodies in mice

scientific article published on 9 February 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 September 2017

A recombinant baculovirus-expressed S glycoprotein vaccine elicits high titers of SARS-associated coronavirus (SARS-CoV) neutralizing antibodies in mice (English)

1 reference

Europe PubMed Central

19 September 2017

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Zhimin Zhou

1

1 reference

Europe PubMed Central

19 September 2017

Penny Post

2

1 reference

Europe PubMed Central

19 September 2017

Rick Chubet

3

1 reference

Europe PubMed Central

19 September 2017

Katherine Holtz

4

1 reference

Europe PubMed Central

19 September 2017

Clifton McPherson

5

1 reference

Europe PubMed Central

19 September 2017

Martin Petric

6

1 reference

Europe PubMed Central

19 September 2017

Manon Cox

7

1 reference

Europe PubMed Central

19 September 2017

language of work or name

0 references

publication date

9 February 2006

1 reference

Europe PubMed Central

19 September 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

19 September 2017

24

1 reference

Europe PubMed Central

19 September 2017

17

1 reference

Europe PubMed Central

19 September 2017

3624-3631

1 reference

Europe PubMed Central

19 September 2017

SARS-Associated Coronavirus

1 reference

https://pubmed.ncbi.nlm.nih.gov/16497416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of a critical neutralization determinant of severe acute respiratory syndrome (SARS)-associated coronavirus: importance for designing SARS vaccines

1 reference

https://pubmed.ncbi.nlm.nih.gov/16497416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The SARS-CoV S glycoprotein

1 reference

https://pubmed.ncbi.nlm.nih.gov/16497416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The SARS-CoV S glycoprotein: expression and functional characterization

1 reference

https://pubmed.ncbi.nlm.nih.gov/16497416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A single immunization with a rhabdovirus-based vector expressing severe acute respiratory syndrome coronavirus (SARS-CoV) S protein results in the production of high levels of SARS-CoV-neutralizing antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/16497416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The development of vaccines against SARS corona virus in mice and SCID-PBL/hu mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/16497416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine

1 reference

https://pubmed.ncbi.nlm.nih.gov/16497416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of immunodominant sites on the spike protein of severe acute respiratory syndrome (SARS) coronavirus: implication for developing SARS diagnostics and vaccines.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16497416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/16497416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/16497416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synthesis and characterization of a native, oligomeric form of recombinant severe acute respiratory syndrome coronavirus spike glycoprotein

1 reference

https://pubmed.ncbi.nlm.nih.gov/16497416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of two neutralizing regions on the severe acute respiratory syndrome coronavirus spike glycoprotein produced from the mammalian expression system.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16497416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adenoviral expression of a truncated S1 subunit of SARS-CoV spike protein results in specific humoral immune responses against SARS-CoV in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/16497416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The molecular biology of coronaviruses

1 reference

https://pubmed.ncbi.nlm.nih.gov/16497416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A novel coronavirus associated with severe acute respiratory syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/16497416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Augmentation of immune responses to SARS coronavirus by a combination of DNA and whole killed virus vaccines

1 reference

https://pubmed.ncbi.nlm.nih.gov/16497416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16497416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-inactivated whole virus candidate SARS coronavirus vaccine stimulates neutralising and protective antibody responses

1 reference

https://pubmed.ncbi.nlm.nih.gov/16497416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2

1 reference

https://pubmed.ncbi.nlm.nih.gov/16497416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

1 reference

https://pubmed.ncbi.nlm.nih.gov/16497416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/16497416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry

1 reference

https://pubmed.ncbi.nlm.nih.gov/16497416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity

1 reference

https://pubmed.ncbi.nlm.nih.gov/16497416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Structure of SARS coronavirus spike receptor-binding domain complexed with receptor

1 reference

https://pubmed.ncbi.nlm.nih.gov/16497416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Laboratory diagnosis of four recent sporadic cases of community-acquired SARS, Guangdong Province, China

1 reference

https://pubmed.ncbi.nlm.nih.gov/16497416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/16497416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neutralizing antibody and protective immunity to SARS coronavirus infection of mice induced by a soluble recombinant polypeptide containing an N-terminal segment of the spike glycoprotein

1 reference

https://pubmed.ncbi.nlm.nih.gov/16497416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of a novel coronavirus associated with severe acute respiratory syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/16497416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

SARS coronavirus spike polypeptide DNA vaccine priming with recombinant spike polypeptide from Escherichia coli as booster induces high titer of neutralizing antibody against SARS coronavirus.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16497416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Severe acute respiratory syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/16497416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inactivated SARS-CoV vaccine elicits high titers of spike protein-specific antibodies that block receptor binding and virus entry

1 reference

https://pubmed.ncbi.nlm.nih.gov/16497416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amino acids 270 to 510 of the severe acute respiratory syndrome coronavirus spike protein are required for interaction with receptor

1 reference

https://pubmed.ncbi.nlm.nih.gov/16497416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Genome sequence of the SARS-associated coronavirus

1 reference

https://pubmed.ncbi.nlm.nih.gov/16497416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Coronavirus as a possible cause of severe acute respiratory syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/16497416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Construction of a eukaryotic expression plasmid encoding partial S gene fragments of the SARS-CoV and its potential utility as a DNA vaccine.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16497416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.VACCINE.2006.01.059

1 reference

Europe PubMed Central

19 September 2017

1 reference

Europe PubMed Central

19 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40312310&oldid=1894998402"